Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Go back to Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
(NASDAQ: FULC) Delayed: 3.78 +0.02 (0.53%)
Previous Close $3.76    52 Week High
Open $3.80    52 Week Low
Day High $3.80    P/E N/A 
Day Low $3.75    EPS
Volume 261,068